This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Selecting a total market ETF for a Roth IRA involves evaluating expense ratios and tracking performance. This guide outlines practical criteria.
28,330 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Tapestry, the company behind Coach and Kate Spade, blends capital planning with daily operations to decide which bran...
As July earnings season looms, investors are scanning three cloud computing stocks before the reports. AI demand and ...
BYDFi joined Peru Blockchain Conference 2026 in Lima, marking a clear LATAM push as the region readies for tighter ru...
Oracle shares slide as Larry Ellison funds a bid to steer a $110 billion media empire, triggering regulatory hurdles ...
Southeast Asia’s fast-growing hospitality is expanding rapidly, but a persistent labor shortage threatens growth as b...
A Nobel Prize–winning economist says U.S. democracy hinges on two policy shifts tied to AI and inequality. He outline...
As AeroVironment approaches its March earnings release, a growing chorus of analysts signals meaningful upside, point...
A rising productivity framework argues that some workplace tasks look busy but deliver little real value. This could ...
Costco reported a sturdy quarterly performance, signaling continued strength in its membership model. The company spo...
Rival AI employees have filed an amicus brief backing Anthropic in a Pentagon-led dispute over a supply-chain risk de...
A Trump-themed meme coin surged as promoters advertised a Mar-a-Lago gala, with White House attendance unconfirmed an...